Antibiotic resistance to Mycobacterium abscessus can be addressed using new technique: Study

Posted on:
Key Points

Tennessee [US], January 5 (ANI): The issue of antibiotic resistance in Mycobacterium abscessus (Mab) is being tackled by researchers at St. Jude Childrens Research Hospital..

To combat this, the researchers created novel spectinomycin formulations that circumvent efflux, the primary mechanism causing resistance..

Scientists at St. Jude modified the naturally occurring antibiotic spectinomycin to create analogs, comparable but structurally distinct N-ethylene linked aminomethyl spectinomycins (eAmSPCs)..

Over the past two decades, weve seen a massive increase in the number of infections caused by non-tuberculous mycobacteria like Mab, said co-first author Gregory Phelps, PharmD, St. Jude Graduate School of Biomedical Sciences..

The researchers also found that eAmSPCs work well with various classes of antibiotics used to treat Mab and retain their activity against other mycobacterial strains..

You might be interested in

New technique addresses antibiotic resistance to Mycobacterium abscessus: Study

07, Jan, 24

The study shows a new technique that can help in addressing the issue of antibiotic resistance in Mycobacterium abscessus. | Health

How antibiotic misuse is creating a health emergency in India

07, Oct, 24

Antibiotics, once hailed as miracle drugs, are losing their effectiveness due to misuse and over-the-counter availability in India, leading to a silent pandemic of antimicrobial resistance.

Superbugs behind fatal blood infections in India rapidly growing resistant to last-resort antibiotics

25, May, 24

Findings published in Lancet based on ICMR data collected from 14 states. Study to help monitor anti-microbial resistance & tailor region-specific treatment plans, researchers say.

Ceftriaxone, among India’s most prescribed antibiotics, ‘increasingly resistant’ against pathogens

07, Jan, 24

Monocef, a popular brand of the drug, has been among top-selling medicines these last few months. Ceftriaxone is ‘watch’ antibiotic, with high potential for antimicrobial resistance.